Literature DB >> 7491558

Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis.

K A Boomars1, S S Wagenaar, P G Mulder, H van Velzen-Blad, J M van den Bosch.   

Abstract

BACKGROUND: The relationship between cell types in bronchoalveolar lavage (BAL) fluid and the clinical course of patients with idiopathic pulmonary fibrosis (IPF) has been the subject of several studies. However, the results of these studies are not conclusive. The aim of this study was to investigate the relationship between the absolute and relative cell numbers in BAL fluid from patients with IPF and their survival.
METHODS: Results obtained from the initial BAL fluid analyses of all histologically proven cases of IPF (n = 49) were selected retrospectively. Cox's proportional hazards survival analysis was used for estimating the relationship between absolute and relative cell numbers and survival.
RESULTS: A negative relationship was found between both the absolute numbers and percentages of eosinophils in BAL fluid samples and survival. No such relationship was demonstrated for the absolute numbers or the percentages of any other cell type.
CONCLUSIONS: Although this study has restrictions, these findings suggest a negative relationship between the absolute numbers and percentages of eosinophils in BAL fluid samples and survival in patients with IPF.

Entities:  

Mesh:

Year:  1995        PMID: 7491558      PMCID: PMC475023          DOI: 10.1136/thx.50.10.1087

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis.

Authors:  M Turner-Warwick; P L Haslam
Journal:  Am Rev Respir Dis       Date:  1987-01

2.  Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.

Authors:  P L Haslam; C W Turton; A Lukoszek; A J Salsbury; A Dewar; J V Collins; M Turner-Warwick
Journal:  Thorax       Date:  1980-05       Impact factor: 9.139

3.  Mast cell and histamine content of human bronchoalveolar lavage fluid.

Authors:  R M Agius; R C Godfrey; S T Holgate
Journal:  Thorax       Date:  1985-10       Impact factor: 9.139

4.  Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.

Authors:  A U Wells; D M Hansell; M B Rubens; P Cullinan; P L Haslam; C M Black; R M Du Bois
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405

5.  Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders.

Authors:  O Kawanami; V J Ferrans; J D Fulmer; R G Crystal
Journal:  Lab Invest       Date:  1979-06       Impact factor: 5.662

6.  Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis.

Authors:  P L Haslam; O Cromwell; A Dewar; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

7.  Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.

Authors:  W B Davis; G A Fells; X H Sun; J E Gadek; A Venet; R G Crystal
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

8.  Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy.

Authors:  L C Watters; M I Schwarz; R M Cherniack; J A Waldron; T L Dunn; R E Stanford; T E King
Journal:  Am Rev Respir Dis       Date:  1987-03

9.  Histamine levels in bronchoalveolar lavage from patients with asthma, sarcoidosis, and idiopathic pulmonary fibrosis.

Authors:  J A Rankin; M Kaliner; H Y Reynolds
Journal:  J Allergy Clin Immunol       Date:  1987-02       Impact factor: 10.793

10.  Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases.

Authors:  P L Haslam; A Dewar; P Butchers; Z S Primett; A Newman-Taylor; M Turner-Warwick
Journal:  Am Rev Respir Dis       Date:  1987-01
View more
  13 in total

Review 1.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Pulmonary vasculitis.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2006

3.  Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.

Authors:  Seung-Ick Cha; Christine S Chang; Eun Kyung Kim; Jae W Lee; Michael A Matthay; Jeffrey A Golden; Brett M Elicker; Kirk Jones; Harold R Collard; Paul J Wolters
Journal:  Histopathology       Date:  2012-03-06       Impact factor: 5.087

4.  Genetic susceptibility to interstitial pulmonary fibrosis in mice induced by vanadium pentoxide (V2O5).

Authors:  Dianne M Walters; Kevin M White; Ushma Patel; Martin J Davis; Roberta M Veluci-Marlow; Solomon Raju Bhupanapadu Sunkesula; James C Bonner; Jessica R Martin; Wes Gladwell; Steven R Kleeberger
Journal:  FASEB J       Date:  2013-11-27       Impact factor: 5.191

5.  Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis.

Authors:  H Mukae; H Iiboshi; M Nakazato; T Hiratsuka; M Tokojima; K Abe; J Ashitani; J Kadota; S Matsukura; S Kohno
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

6.  Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.

Authors:  Charlie Strange; Marcy B Bolster; Michael D Roth; Richard M Silver; Arthur Theodore; Jonathan Goldin; Philip Clements; Joanie Chung; Robert M Elashoff; Robert Suh; Edwin A Smith; Daniel E Furst; Donald P Tashkin
Journal:  Am J Respir Crit Care Med       Date:  2007-09-27       Impact factor: 21.405

7.  Early interstitial lung disease in familial pulmonary fibrosis.

Authors:  Ivan O Rosas; Ping Ren; Nilo A Avila; Catherine K Chow; Teri J Franks; William D Travis; J Philip McCoy; Rose M May; Hai-Ping Wu; Dao M Nguyen; Mauricio Arcos-Burgos; Sandra D MacDonald; Bernadette R Gochuico
Journal:  Am J Respir Crit Care Med       Date:  2007-07-19       Impact factor: 21.405

8.  Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis.

Authors:  Ali Emad; Yasaman Emad
Journal:  J Clin Immunol       Date:  2007-07-10       Impact factor: 8.317

Review 9.  Immune dysregulation as a driver of idiopathic pulmonary fibrosis.

Authors:  Kevin Shenderov; Samuel L Collins; Jonathan D Powell; Maureen R Horton
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 10.  Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response.

Authors:  Willis S Bowman; Gabrielle A Echt; Justin M Oldham
Journal:  Front Med (Lausanne)       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.